Form D · Other

RUBY BIO, INC.

San Carlos, CA · CIK 0001947546

Offering snapshot reported Jun 9, 2025 · SEC filing

Reported sold
$7.98M
Offering amount: $8.98M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 15, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 9, 2025Initial$7,979,015No comparison22SEC filing
Aug 31, 2023Amendment$5,138,717$4,338,717vs Sep 22, 202214SEC filing
Sep 22, 2022Initial$800,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-548353
Total Offering Amount includes the conversion of $6,479,017 of convertible securities.

Source: Form D, filed Jun 9, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Pavan Kambam Director, Executive, Promoter
Vaibhav Kumar Director
Brian Rigert Director
Charles Silver Director, Executive, Promoter
Kevin Yanos Executive

Issuer details

Industry: Other (See others in industry)

Address:
733 Industrial Drive
San Carlos, CA, 94070